Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

Proteins have a remarkable ability to carry out complex molecular processes with high efficiency and precision, characteristics that make them ideal for use in medicine and industry. Protein ...

Flow cytometry detects cells or particles in suspension by separating them in a narrow, rapidly flowing stream of liquid. The sample is passed through a laser, which detects properties such as size, ...

The brain’s chatter has always been partly out of reach, with electrical spikes easy to record but the chemical whispers ...

Therapeutic protein design is evolving—and it is doing so in more than one sense of that word. Protein design is being guided by artificial intelligence (AI), which drug developers are using to ...

The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering.Enhance your knowledge in protein ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

New method accelerates protein engineering by using structural and evolutionary constraints in inverse folding models without training specialized AI systems. (Nanowerk News) A team of Chinese ...

It was the year protein was oversold, overvalued and overhyped. The science of protein has not changed; we just need to ...

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, today announced a USD $12 million ...